TeamViewer (TMV) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
16 Nov, 2025Executive summary
Achieved 6% pro forma revenue growth year-over-year in Q2 2025 at constant currency, with enterprise revenue up 15% and strong momentum from new product launches and 1E integration.
Adjusted EBITDA increased 17% year-over-year, with margin expanding to 44%, up 4 percentage points.
Net income for Q2 2025 was EUR 27.6 million, up 4% year-over-year; adjusted EPS increased 19% to EUR 0.28.
Despite U.S. macroeconomic headwinds, EMEA and APAC delivered strong results, and key federal clients were retained.
Full-year 2025 guidance reiterated, with growth acceleration expected in H2.
Financial highlights
Q2 2025 pro forma revenue reached EUR 191 million, up 6% year-over-year in constant currency.
Pro forma adjusted EBITDA was EUR 84 million, up 17% year-over-year, with margin at 44%.
Pro forma adjusted EPS increased 19% year-over-year to EUR 0.28.
ARR grew 4% year-over-year in constant currency, reaching EUR 759 million.
Levered free cash flow was EUR 59.6 million in Q2, with 71% cash conversion.
Outlook and guidance
Full-year 2025 guidance reiterated: ARR expected between EUR 815–840 million (7.5–10.8% growth), revenue between EUR 778–797 million (5.1–7.7% growth), and adjusted EBITDA margin around 43%.
Growth acceleration anticipated in H2, driven by seasonality, larger pipeline, and improved conversion rates.
Cash conversion rate for the year expected around 70%.
Leverage target of 2.6x by year-end 2025 and below 2x by end of 2026.
Management expects reported IFRS revenue and margin to be slightly lower than pro forma due to acquisition-related adjustments.
Latest events from TeamViewer
- 5% revenue and 8% EBITDA growth in 2025; 2026 outlook cautious with 0–3% growth target.TMV
Q4 202510 Feb 2026 - Q2 2024 delivered strong growth, high margins, and reaffirmed full-year guidance.TMV
Q2 20242 Feb 2026 - Enterprise momentum and cost discipline drove strong Q3 growth and profitability.TMV
Q3 202416 Jan 2026 - $720M deal creates a DEX leader, targeting double-digit growth and global expansion by 2027.TMV
M&A Announcement11 Jan 2026 - FY 2024 exceeded guidance with strong Enterprise growth, 1E integration, and margin expansion.TMV
Q4 202416 Dec 2025 - Enterprise ARR up 21%, revenue and EBITDA both rise 7% and 20% year-over-year, outlook confirmed.TMV
Q1 202519 Nov 2025 - Q3 delivered 4% growth and 46% margin, but 1E weakness led to lower ARR guidance for 2025.TMV
Q3 202522 Oct 2025